• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Vivalink Launches Multi-Vital Blood Pressure Patch for Remote Patient Monitoring

by Fred Pennic 05/03/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Vivalink Launches Multi-Vital Blood Pressure Patch for Remote Patient Monitoring

What You Should Know:

– Vivalink, a leading provider of digital healthcare solutions launches a multi-vital blood pressure patch for remote patient monitoring is now available for research and development.

– The advanced multimodal continuous signal processing patch captures ECG trace, heart rate, respiratory rate, systolic and diastolic blood pressure on a single device.

Cuffless Blood Pressure Monitor

Cuffless blood pressure is still in its infancy, but new research is exploring the use of a promising, FDA- and CE-cleared electrical-signal-based technology, unlike other cuffless monitors. Previous cuffless blood pressure monitors have used optical sensing or light-based monitoring, which is known to have issues with data capture accuracy, light sensitivity, and efficacy across skin tones.

Designed for remote and ambulatory patient monitoring such as hypertension diagnosis and management, the patch is wireless network-enabled to automatically capture and send a continuous stream of data to clinical applications in the cloud. In addition, the patch contains onboard memory in order to capture data during network outages, and then automatically synchronize the data once network connections are re-established.

The device is FDA/NMPA cleared for ECG and heart rate, and CE cleared for ECG, heart rate and respiratory rate. The blood pressure feature is integrated and available for research and development. Weighing just 7.5 grams and the size of a small bandage, the reusable and rechargeable wearable patch requires no additional components such as a wristband or wires in order to capture blood pressure.

To date, the device is FDA/NMPA cleared for ECG and heart rate, and CE cleared for ECG, heart rate and respiratory rate. Vivalink’s electrical-signal-based technology has shown promising signs of mitigating those challenges. In addition, unlike other cuffless blood pressure technologies, Vivalink’s reusable/rechargeable wearable patch is calibration-free and requires no additional components such as a wristband or wires in order to capture blood pressure.

Availability

The multi-vital blood pressure patch is available now for commercial research and development.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Blood Pressure, Blood Pressure Monitors, cloud, Digital Healthcare, ecg, FDA, Heart, Hypertension, Patient Monitoring, remote patient monitoring, Vital

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |